Certain Botulinum Toxin Products, Processes for Manufacturing or Relating to Same and Certain Products Containing Same; Notice of Request for Statements on the Public Interest, 46711-46712 [2020-16724]
Download as PDF
Federal Register / Vol. 85, No. 149 / Monday, August 3, 2020 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Allamakee County, IA, by NPS
archeologist Paul Beaubien. The railroad
had cut through the deposit, exposing
human remains and artifacts. The
human remains did not enter Effigy
Mounds National Monument collections
and their whereabouts is unknown. The
112 unassociated funerary objects are
110 pottery sherds and two fish bones.
Sometime between 1958 and 1963,
277 cultural items were removed from
the Waukon Junction Rockshelter in
Allamakee County, IA, by unknown
persons, probably as the site was being
impacted by highway construction. In
1986, human remains collected with the
objects were transferred to the Iowa
Office of the State Archaeologist and
retained under the authority of the 1976
Iowa Burial Law. The 277 unassociated
funerary objects are one shell tool, 87
freshwater mussel shells, two bifaces,
one flake, eight unmodified stones, 20
pottery sherds, four utilized flakes, one
bone ornament, one modified flake, 147
faunal bones, one stone tool, two
woodland variant Tama projectile
points, one piece of shatter, and one
bone awl.
Based on archeological context,
ethnographic information, and oral
traditions the unassociated funerary
objects described above are identified as
belonging to the Woodland tradition.
The Woodland tradition transitions into
the Oneota tradition which is identified
as being clearly ancestral to the HoChunk Nation of Wisconsin.
Determinations Made by the U.S.
Department of the Interior, National
Park Service, Effigy Mounds National
Monument
Officials of the U.S. Department of the
Interior, National Park Service, Effigy
Mounds National Monument have
determined that:
• Pursuant to 25 U.S.C. 3001(3)(B),
the 392 cultural items described above
are reasonably believed to have been
placed with or near individual human
remains at the time of death or later as
part of the death rite or ceremony and
are believed, by a preponderance of the
evidence, to have been removed from a
specific burial site of a Native American
individual.
• Pursuant to 25 U.S.C. 3001(2), there
is a relationship of shared group
identity that can be reasonably traced
between the unassociated funerary
objects and the Ho-Chunk Nation of
Wisconsin.
Additional Requestors and Disposition
Lineal descendants or representatives
of any Indian Tribe or Native Hawaiian
organization not identified in this notice
that wish to claim these cultural items
VerDate Sep<11>2014
20:39 Jul 31, 2020
Jkt 250001
should submit a written request with
information in support of the claim to
Jim Nepstad, Superintendent, Effigy
Mounds National Monument, 151 Hwy
76, Harpers Ferry, IA 52146, telephone
(563) 873–3491 Ext. 101, email jim_
nepstad@nps.gov, by September 2, 2020.
After that date, if no additional
claimants have come forward, transfer
of control of the unassociated funerary
objects to the Ho-Chunk Nation of
Wisconsin may proceed.
The U.S. Department of the Interior,
National Park Service, Effigy Mounds
National Monument is responsible for
notifying the Crow Creek Sioux Tribe of
the Crow Creek Reservation, South
Dakota; Flandreau Santee Sioux Tribe of
South Dakota; Ho-Chunk Nation of
Wisconsin; Iowa Tribe of Kansas and
Nebraska; Iowa Tribe of Oklahoma;
Lower Sioux Indian Community in the
State of Minnesota; Omaha Tribe of
Nebraska; Otoe-Missouria Tribe of
Indians, Oklahoma; Ponca Tribe of
Nebraska; Prairie Island Indian
Community in the State of Minnesota;
Sac & Fox Nation of Missouri in Kansas
and Nebraska; Sac & Fox Nation,
Oklahoma; Sac & Fox Tribe of the
Mississippi in Iowa; Santee Sioux
Nation, Nebraska; Shakopee
Mdewakanton Sioux Community of
Minnesota; Sisseton-Wahpeton Oyate of
the Lake Traverse Reservation, South
Dakota; Standing Rock Sioux Tribe of
North & South Dakota; Upper Sioux
Community, Minnesota; Winnebago
Tribe of Nebraska; and the Yankton
Sioux Tribe of South Dakota that this
notice has been published.
Dated: June 25, 2020.
Melanie O’Brien,
Manager, National NAGPRA Program.
[FR Doc. 2020–16779 Filed 7–31–20; 8:45 am]
BILLING CODE 4312–52–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1145]
Certain Botulinum Toxin Products,
Processes for Manufacturing or
Relating to Same and Certain Products
Containing Same; Notice of Request
for Statements on the Public Interest
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the presiding administrative law judge
has issued a Final Initial Determination
on Section 337 Violation and a
Recommended Determination on
Remedy and Bonding in the above-
SUMMARY:
PO 00000
Frm 00126
Fmt 4703
Sfmt 4703
46711
captioned investigation. The
Commission is soliciting comments on
public interest issues raised by the
recommended relief, should the
Commission find a violation. This
notice is soliciting public interest
comments from the public only. Parties
are to file public interest submissions
pursuant to Commission rules.
FOR FURTHER INFORMATION CONTACT:
Houda Morad, Office of the General
Counsel, U.S. International Trade
Commission, 500 E Street SW,
Washington, DC 20436, telephone (202)
708–4716. Copies of non-confidential
documents filed in connection with this
investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. For help
accessing EDIS, please email
EDIS3Help@usitc.gov. General
information concerning the Commission
may also be obtained by accessing its
internet server at https://www.usitc.gov.
The public record for this investigation
may be viewed on the Commission’s
electronic docket (EDIS) at https://
edis.usitc.gov. Hearing-impaired
persons are advised that information on
this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810.
SUPPLEMENTARY INFORMATION: Section
337 of the Tariff Act of 1930 (‘‘Section
337’’) provides that if the Commission
finds a violation it shall exclude the
articles concerned from the United
States unless the public interest factors
listed in 19 U.S.C. 1337(d)(1) prevent
such action. A similar provision applies
to cease and desist orders. 19 U.S.C.
1337(f)(1).
The Commission is soliciting
comments on public interest issues
raised by the recommended relief
should the Commission find a violation,
specifically whether the Commission
should issue: (1) A limited exclusion
order (‘‘LEO’’) against certain botulinum
toxin products that are imported, sold
for importation, and/or sold after
importation by respondents Daewoong
Pharmaceuticals Co., Ltd. of Seoul,
South Korea (‘‘Daewoong’’) and Evolus,
Inc. of Irvine, California (‘‘Evolus’’); and
(2) a cease and desist order (‘‘CDO’’)
against Evolus.
The Commission is interested in
further development of the record on
the public interest in this investigation.
Accordingly, parties are to file public
interest submissions pursuant to 19 CFR
210.50(a)(4). In addition, members of
the public are hereby invited to file
submissions of no more than five (5)
pages, inclusive of attachments,
concerning the public interest in light of
the administrative law judge’s
E:\FR\FM\03AUN1.SGM
03AUN1
khammond on DSKJM1Z7X2PROD with NOTICES
46712
Federal Register / Vol. 85, No. 149 / Monday, August 3, 2020 / Notices
Recommended Determination on
Remedy and Bonding issued in this
investigation on July 6, 2020. Comments
should address whether issuance of the
LEO and CDO in this investigation,
should the Commission find a violation,
would affect the public health and
welfare in the United States,
competitive conditions in the United
States economy, the production of like
or directly competitive articles in the
United States, or United States
consumers.
In particular, the Commission is
interested in comments that:
(i) Explain how the articles
potentially subject to the recommended
orders are used in the United States;
(ii) Identify any public health, safety,
or welfare concerns in the United States
relating to the recommended orders;
(iii) Identify like or directly
competitive articles that complainants,
their licensees, or third parties make in
the United States which could replace
the subject articles if they were to be
excluded;
(iv) Indicate whether complainants,
complainants’ licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to the recommended
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) Explain how the LEO and CDO
would impact consumers in the United
States.
Written submissions from the public
must be filed no later than by close of
business on August 18, 2020.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above. The Commission’s paper
filing requirements in 19 CFR 210.4(f)
are currently waived. 85 FR 15798
(March 19, 2020). Submissions should
refer to the investigation number (‘‘Inv.
No. 337–TA–1145’’) in a prominent
place on the cover page and/or the first
page. See Handbook for Electronic
Filing Procedures, https://
www.usitc.gov/documents/handbook_
on_filing_procedures.pdf. Persons with
questions regarding filing should
contact the Secretary (202–205–2000).
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
VerDate Sep<11>2014
20:39 Jul 31, 2020
Jkt 250001
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel, solely for cybersecurity
purposes. All contract personnel will
sign appropriate nondisclosure
agreements. All non-confidential
written submissions will be available for
public inspection at the Office of the
Secretary and on EDIS.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: July 28, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–16724 Filed 7–31–20; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 332–577]
Raspberries for Processing:
Conditions of Competition Between
U.S. and Foreign Suppliers, with a
Focus on Washington State; Change in
Form of Public Hearing
United States International
Trade Commission.
ACTION: Change in form of public
hearing.
AGENCY:
The Commission has changed
the form of the hearing to be held in
Investigation No. 332–577: Raspberries
for Processing: Conditions of
Competition between U.S. and Foreign
Suppliers, with a Focus on Washington
State, from an in-person hearing to a
videoconference hearing due to COVID–
19. With the exception of an additional
date for filing electronic copies of oral
statements for the hearing, dates
previously announced in the notice of
investigation remain the same.
DATES:
SUMMARY:
PO 00000
Frm 00127
Fmt 4703
Sfmt 4703
August 27, 2020: Deadline for filing
requests to appear at the public hearing.
September 8, 2020: Deadline for filing
prehearing briefs and statements.
September 15, 2020: Deadline for
filing electronic copies of oral
statements to be presented at the
hearing.
September 17, 2020: Public hearing
via videoconference.
September 24, 2020: Deadline for
filing post-hearing briefs and
statements.
December 6, 2020: Deadline for filing
all other written submissions.
June 9, 2021: Transmittal of
Commission report to the United States
Trade Representative.
ADDRESSES: All Commission offices,
including the Commission’s hearing
rooms, are located in the United States
International Trade Commission
Building, 500 E Street SW, Washington,
DC. All written submissions should be
addressed to the Secretary, United
States International Trade Commission,
500 E Street SW, Washington, DC
20436. The public record for this
investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov/edis3-internal/
app. Please note the Secretary’s Office
will accept only electronic filings at this
time (see SUPPLEMENTARY INFORMATION
or Written Submissions for more
information).
FOR FURTHER INFORMATION CONTACT:
Project Leader Jessica Pugliese (202–
941–9537 or jessica.pugliese@usitc.gov)
or Deputy Project Leader Mary Roop
(202–708–2277 or mary.roop@usitc.gov)
for information specific to this
investigation. For information on the
legal aspects of these investigations,
contact William Gearhart of the
Commission’s Office of the General
Counsel (202–205–3091 or
william.gearhart@usitc.gov). The media
should contact Margaret O’Laughlin,
Office of External Relations (202–205–
1819 or margaret.olaughlin@usitc.gov).
Hearing-impaired individuals may
obtain information on this matter by
contacting the Commission’s TDD
terminal at 202–205–1810. General
information concerning the Commission
may also be obtained by accessing its
internet server (https://www.usitc.gov).
Persons with mobility impairments who
will need special assistance in gaining
access to the Commission should
contact the Office of the Secretary at
202–205–2000.
SUPPLEMENTARY INFORMATION: The
public hearing in this investigation will
be held beginning at 9:30 a.m. on
September 17, 2020, using a
videoconference platform. More
E:\FR\FM\03AUN1.SGM
03AUN1
Agencies
[Federal Register Volume 85, Number 149 (Monday, August 3, 2020)]
[Notices]
[Pages 46711-46712]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16724]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1145]
Certain Botulinum Toxin Products, Processes for Manufacturing or
Relating to Same and Certain Products Containing Same; Notice of
Request for Statements on the Public Interest
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the presiding administrative law
judge has issued a Final Initial Determination on Section 337 Violation
and a Recommended Determination on Remedy and Bonding in the above-
captioned investigation. The Commission is soliciting comments on
public interest issues raised by the recommended relief, should the
Commission find a violation. This notice is soliciting public interest
comments from the public only. Parties are to file public interest
submissions pursuant to Commission rules.
FOR FURTHER INFORMATION CONTACT: Houda Morad, Office of the General
Counsel, U.S. International Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202) 708-4716. Copies of non-
confidential documents filed in connection with this investigation may
be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email
[email protected]. General information concerning the Commission may
also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed
on the Commission's electronic docket (EDIS) at https://edis.usitc.gov.
Hearing-impaired persons are advised that information on this matter
can be obtained by contacting the Commission's TDD terminal on (202)
205-1810.
SUPPLEMENTARY INFORMATION: Section 337 of the Tariff Act of 1930
(``Section 337'') provides that if the Commission finds a violation it
shall exclude the articles concerned from the United States unless the
public interest factors listed in 19 U.S.C. 1337(d)(1) prevent such
action. A similar provision applies to cease and desist orders. 19
U.S.C. 1337(f)(1).
The Commission is soliciting comments on public interest issues
raised by the recommended relief should the Commission find a
violation, specifically whether the Commission should issue: (1) A
limited exclusion order (``LEO'') against certain botulinum toxin
products that are imported, sold for importation, and/or sold after
importation by respondents Daewoong Pharmaceuticals Co., Ltd. of Seoul,
South Korea (``Daewoong'') and Evolus, Inc. of Irvine, California
(``Evolus''); and (2) a cease and desist order (``CDO'') against
Evolus.
The Commission is interested in further development of the record
on the public interest in this investigation. Accordingly, parties are
to file public interest submissions pursuant to 19 CFR 210.50(a)(4). In
addition, members of the public are hereby invited to file submissions
of no more than five (5) pages, inclusive of attachments, concerning
the public interest in light of the administrative law judge's
[[Page 46712]]
Recommended Determination on Remedy and Bonding issued in this
investigation on July 6, 2020. Comments should address whether issuance
of the LEO and CDO in this investigation, should the Commission find a
violation, would affect the public health and welfare in the United
States, competitive conditions in the United States economy, the
production of like or directly competitive articles in the United
States, or United States consumers.
In particular, the Commission is interested in comments that:
(i) Explain how the articles potentially subject to the recommended
orders are used in the United States;
(ii) Identify any public health, safety, or welfare concerns in the
United States relating to the recommended orders;
(iii) Identify like or directly competitive articles that
complainants, their licensees, or third parties make in the United
States which could replace the subject articles if they were to be
excluded;
(iv) Indicate whether complainants, complainants' licensees, and/or
third party suppliers have the capacity to replace the volume of
articles potentially subject to the recommended exclusion order and/or
a cease and desist order within a commercially reasonable time; and
(v) Explain how the LEO and CDO would impact consumers in the
United States.
Written submissions from the public must be filed no later than by
close of business on August 18, 2020.
Persons filing written submissions must file the original document
electronically on or before the deadlines stated above. The
Commission's paper filing requirements in 19 CFR 210.4(f) are currently
waived. 85 FR 15798 (March 19, 2020). Submissions should refer to the
investigation number (``Inv. No. 337-TA-1145'') in a prominent place on
the cover page and/or the first page. See Handbook for Electronic
Filing Procedures, https://www.usitc.gov/documents/handbook_on_filing_procedures.pdf. Persons with questions regarding
filing should contact the Secretary (202-205-2000).
Any person desiring to submit a document to the Commission in
confidence must request confidential treatment. All such requests
should be directed to the Secretary to the Commission and must include
a full statement of the reasons why the Commission should grant such
treatment. See 19 CFR 201.6. Documents for which confidential treatment
by the Commission is properly sought will be treated accordingly. All
information, including confidential business information and documents
for which confidential treatment is properly sought, submitted to the
Commission for purposes of this Investigation may be disclosed to and
used: (i) By the Commission, its employees and Offices, and contract
personnel (a) for developing or maintaining the records of this or a
related proceeding, or (b) in internal investigations, audits, reviews,
and evaluations relating to the programs, personnel, and operations of
the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract personnel, solely for cybersecurity
purposes. All contract personnel will sign appropriate nondisclosure
agreements. All non-confidential written submissions will be available
for public inspection at the Office of the Secretary and on EDIS.
The authority for the Commission's determination is contained in
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and
in part 210 of the Commission's Rules of Practice and Procedure (19 CFR
part 210).
By order of the Commission.
Issued: July 28, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020-16724 Filed 7-31-20; 8:45 am]
BILLING CODE 7020-02-P